TELO logo
TELO

Telomir Pharmaceuticals Inc

Pharmaceuticals

Telomir Pharmaceuticals Inc (TELO) Earnings

Last reported
May 12, 2026
EPS estimate
-$0.07
EPS actual
—
Revenue est.
—
Revenue actual
—